Optimising the Treatment Pathway in HER2+ Breast Cancer: From Neoadjuvant Therapy to Surgery
The webinar "Optimising the treatment pathway in HER2-positive breast cancer: from neoadjuvant therapy to surgery" is a specialized educational session scheduled for February 2, 2026, at 18:00 CET. Part of the European Union-funded DEFINITIVE project, this session examines the critical interface between systemic neoadjuvant management and evolving surgical standards for HER2-positive breast cancer. A multidisciplinary […]